We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Children's Place Appears to be a Solid Pick Now
Read MoreHide Full Article
The Children's Place, Inc.(PLCE - Free Report) appears to be a preferred pick, given its sturdy efforts to remain on growth trajectory. We expect the company to continue gaining from its focus on multi-year strategic growth initiatives comprising product, alternate channels of distribution, digital transformation, fleet optimization and international expansion. These efforts also helped the company to post better-than-expected first-quarter fiscal 2019 results, prompting management to lift fiscal 2019 view.
All said, let’s delve deeper into the factors, which have been driving this Zacks Rank #1 (Strong Buy) stock. Shares of this Secaucus, NJ-based company have increased approximately 6% in the past six months, against the industry’s decline of 15.2%.
Factors Driving Children's Place Performance
Children's Place is leaving no stone unturned to improve the top-line performance and expand customer base. The company is making efforts to expand footprint not only in the U.S. market but also globally. This is evident from its license agreement with Zhejiang Semir Garment Co. Ltd (“Semir”) for the Greater China market, which covers Mainland China, Taiwan, Hong Kong and Macau.
Also, the company is focusing on digital transformation. It had rolled out "BOPIS" (Buy Online, Pick Up in Store), Ship from Store, and mobile POS to all its U.S. stores. Further, the company launched SMS texting capabilities and is implementing “BOSS” (Buy Online, Ship to Store). Notably, e-commerce penetration expanded 270 basis points to 29% of net sales during the first quarter of fiscal 2019. E-commerce penetration is projected to increase more than 30% of net sales in fiscal 2019 from approximately 28% in fiscal 2018.
Apart from these, the company’s store fleet optimization plan focuses on striking the right balance between digital and physical stores. Thus, it had closed 213 stores since 2013, till the end of the first quarter of fiscal 2019 and targets a closure of 300 stores by 2020. The company closed 42 stores in fiscal 2018, and plans to close 40-45 stores in fiscal 2019 and again roughly 45 stores in fiscal 2020. Children's Place has also planned 1000 lease renewals over the next three years. The company had earlier informed that this fleet optimization initiative will help it to achieve a 200-basis point improvement in operating margin from 2013 to 2020.
As a result of Gymboree’s bankruptcy, Children's Place intends to open 25 stores in centers with high productivity within a span of two years. The company entered into an Asset Purchase Agreement with Gymboree Group, Inc. and related entities to buy intellectual property assets of Gymboree and Crazy 8 (the “Gymboree Assets”) for $76 million. This buyout is likely to be accretive to fiscal 2020 adjusted earnings per share. Further, the company remains on track for an early 2020 rollout of the Gymboree product line.
L Brands, Inc. has a long-term earnings growth rate of 11% and a Zacks Rank #2.
Stitch Fix, Inc. (SFIX - Free Report) has a long-term earnings growth rate of 22.5% and a Zacks Rank #2.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Here's Why Children's Place Appears to be a Solid Pick Now
The Children's Place, Inc.(PLCE - Free Report) appears to be a preferred pick, given its sturdy efforts to remain on growth trajectory. We expect the company to continue gaining from its focus on multi-year strategic growth initiatives comprising product, alternate channels of distribution, digital transformation, fleet optimization and international expansion. These efforts also helped the company to post better-than-expected first-quarter fiscal 2019 results, prompting management to lift fiscal 2019 view.
All said, let’s delve deeper into the factors, which have been driving this Zacks Rank #1 (Strong Buy) stock. Shares of this Secaucus, NJ-based company have increased approximately 6% in the past six months, against the industry’s decline of 15.2%.
Factors Driving Children's Place Performance
Children's Place is leaving no stone unturned to improve the top-line performance and expand customer base. The company is making efforts to expand footprint not only in the U.S. market but also globally. This is evident from its license agreement with Zhejiang Semir Garment Co. Ltd (“Semir”) for the Greater China market, which covers Mainland China, Taiwan, Hong Kong and Macau.
Also, the company is focusing on digital transformation. It had rolled out "BOPIS" (Buy Online, Pick Up in Store), Ship from Store, and mobile POS to all its U.S. stores. Further, the company launched SMS texting capabilities and is implementing “BOSS” (Buy Online, Ship to Store). Notably, e-commerce penetration expanded 270 basis points to 29% of net sales during the first quarter of fiscal 2019. E-commerce penetration is projected to increase more than 30% of net sales in fiscal 2019 from approximately 28% in fiscal 2018.
Apart from these, the company’s store fleet optimization plan focuses on striking the right balance between digital and physical stores. Thus, it had closed 213 stores since 2013, till the end of the first quarter of fiscal 2019 and targets a closure of 300 stores by 2020. The company closed 42 stores in fiscal 2018, and plans to close 40-45 stores in fiscal 2019 and again roughly 45 stores in fiscal 2020. Children's Place has also planned 1000 lease renewals over the next three years. The company had earlier informed that this fleet optimization initiative will help it to achieve a 200-basis point improvement in operating margin from 2013 to 2020.
As a result of Gymboree’s bankruptcy, Children's Place intends to open 25 stores in centers with high productivity within a span of two years. The company entered into an Asset Purchase Agreement with Gymboree Group, Inc. and related entities to buy intellectual property assets of Gymboree and Crazy 8 (the “Gymboree Assets”) for $76 million. This buyout is likely to be accretive to fiscal 2020 adjusted earnings per share. Further, the company remains on track for an early 2020 rollout of the Gymboree product line.
3 Stocks to Watch
Skechers U.S.A., Inc. (SKX - Free Report) has a long-term earnings growth rate of 7% and a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
L Brands, Inc. has a long-term earnings growth rate of 11% and a Zacks Rank #2.
Stitch Fix, Inc. (SFIX - Free Report) has a long-term earnings growth rate of 22.5% and a Zacks Rank #2.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>